---
layout: minimal-medicine
title: Gadoterate Meglumine
---

# Gadoterate Meglumine
### Generic Name
Gadoterate Meglumine

### Usage
Gadoterate meglumine is a gadolinium-based contrast agent used intravenously with magnetic resonance imaging (MRI). Its primary use is to enhance the visualization of brain and spine tissues, aiding in the detection of areas with a disrupted blood-brain barrier (BBB) or abnormal vascularity. This makes it invaluable in diagnosing various neurological conditions.  While primarily used for central nervous system (CNS) imaging in adults and children (including newborns), it's important to note that its use is strictly for MRI enhancement and not for therapeutic purposes.


### Dosage

**CNS imaging (Adults and Pediatrics):**

*   **Intravenous (IV) bolus injection:** The standard dose is 0.2 mL/kg (0.1 mmol/kg) body weight.  The injection should be administered manually or via a power injector at a flow rate of approximately 1-2 mL/sec for children and approximately 2 mL/sec for adults. Imaging can commence immediately following administration.

**Dosage Adjustments:**

*   **Hepatic Impairment:** No dosage adjustment is specified by the manufacturer.
*   **Renal Impairment:** No specific dosage adjustment is recommended, however,  extreme caution is advised.  The risk of nephrogenic systemic fibrosis (NSF) significantly increases with declining renal function.  Gadoterate meglumine is removed by hemodialysis.


### Side Effects

**Common (1-10%):**

*   Headache
*   Nausea

**Less Common (<1%, post-marketing and/or case reports):**  These are serious but less frequent side effects.  Seek immediate medical attention if any of these occur.

*   Altered sense of smell
*   Anaphylactoid reaction
*   Anaphylaxis
*   Angioedema
*   Cardiac arrest
*   Convulsions
*   Hypersensitivity reaction
*   Nephrogenic systemic fibrosis (NSF) â€“ a serious and potentially life-threatening condition (see Precautions)
*   Injection site reactions (pain, swelling, inflammation)
*   Respiratory arrest


### How it Works

Gadoterate meglumine is a paramagnetic molecule.  When placed in a magnetic field during an MRI scan, it alters the magnetic properties of surrounding water molecules. This alteration enhances the signal intensity of tissues on the MRI images, making areas with disrupted blood-brain barriers or abnormal blood vessels more visible.  It does *not* cross an intact BBB; therefore, it only enhances areas where the barrier is compromised, such as in tumors, abscesses, or areas of inflammation.


### Precautions

*   **Contraindications:** Hypersensitivity to gadoterate meglumine or any component of the formulation; subarachnoid or epidural administration.
*   **Warnings:**  There's an increased risk of extravasation (leakage from the vein during injection), injection-site reactions, gadolinium retention, hypersensitivity reactions, nephrogenic systemic fibrosis (NSF), and acute kidney injury.
*   **Renal Impairment:** Use with extreme caution in patients with renal impairment.  The risk of NSF is significantly higher in patients with reduced kidney function.
*   **Pregnancy:** Gadoterate meglumine is a Category C drug during pregnancy. It should only be used if the benefits clearly outweigh the potential risks to the fetus.
*   **Breastfeeding:**  Excretion in breast milk is unknown.  Mothers should weigh the risks and benefits of breastfeeding while using this medication.  Temporary cessation of breastfeeding may be considered.  Consult a healthcare professional for advice.


### FAQs

*   **Q: How is Gadoterate meglumine administered?** A: It's administered intravenously as a bolus injection.

*   **Q: What should I do if I experience side effects?** A: Report any side effects, especially serious ones, to your doctor or healthcare provider immediately.

*   **Q: Is Gadoterate meglumine safe for people with kidney problems?** A:  Use in patients with kidney problems should be approached with extreme caution due to a significantly increased risk of nephrogenic systemic fibrosis (NSF).

*   **Q: How is Gadoterate meglumine stored?** A: Follow the specific storage instructions provided by your pharmacist or healthcare professional.

*   **Q: Is Gadoterate meglumine a treatment or diagnostic tool?** A: It's a diagnostic contrast agent used to enhance MRI images, not a treatment for any medical condition.

**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult your doctor or healthcare provider before using any medication, including Gadoterate meglumine.  The information provided here is based on the data supplied and may not encompass all possible side effects, interactions, or precautions.  Always refer to the official prescribing information for the most accurate and up-to-date details.
